Who it works for
Fortune favors the brave
Our way of working is not for everyone, it takes a bold leader to shift away from traditional consulting and ways of working. But if you never do things differently, you always get the same results.
Who the Genioo Way works best for
Our purpose and values are at the heart of our people and embedded in our processes. We see the most success with clients who share in our values and beliefs.
When you work with us, we believe in doing it together, not doing it for you. We take a people-centric approach focused on collaboration, communication, and co-creation. Buy-in from everyone is critical to success and this sometimes means tough conversations and going slow at the start to go fast later. Your team will take an active role from the outset. Commitment from both sides will deliver the full value from your vision.
See if the Genioo Way is the right way for you.
When and where it works
Leaders in life science companies know us for successfully delivering complex and cross-functional business transformations. When you want to deliver significant results quickly and build deep-rooted organizational capabilities, call us.
We can partner with you across the end-to-end product lifecycle. Our teams bring a breadth and depth of experience managing transformations and programs with highly-specialized industry and functional expertise. We aim to complement your teams capacity and capabilites across the whole project or just on specific initiatives and tasks.
The Genioo Way works in any and every function. And it can be scaled up or down to work across large scale transformations or complex cross-functional projects. We have the right experience to help you where you need it.
Take a look at how the Genioo Way can help you
Our work with R&D improves development and launch operations and deepens relationships with Pre-clinical, Clinical, Medical Affairs, Pharmacovigilance, and Commercial teams. It includes:
- Portfolio and resource management
- Product launch readiness
- Process opitmization
- R&D efficiency and productivity
- Capability building and change management
Our work with Procurement spans direct and indirect procurement across all functions and categories and includes:
- Transforming procurement into a strategic business value driver
- Procurement operating model development
- Opportunity and gap assessment (overall and by category)
- Supplier negotiation excellence training and support
- Capability building and change management
- Digital enablement for automation, AI, and advanced analytics
Our work with TechOps & Supply Chain covers all areas of Chemicals, Controls, and Manufacturing and deepens the partnership with Procurement, R&D, and Commercial teams. It includes:
- TechOps organizational transformation
- Supply chain management
- Cost optimization and cost containment
- Manufacturing network optimization and operational improvement
- Digital enablement for automation, AI, and advanced analytics
Our work with Quality meets all regulatory requirements across TechOps & Supply Chain, R&D, Clinical, Market Access, and Medical Affairs. It includes:
- FDA audits and remediation including FDA 483 notice remediation
- Quality Spend Efficiency (QSE) through quick wins and structural changes
- Product launches and portfolio and lifecycle management
- Quality organizational model design and implementation at global, regional, and local levels
Our work with Commercial teams helps connect go-to-market strategy considerations to Finance, R&D, Clinical, TechOps, Market Access, and Medical Affairs. It includes:
- Market insights and assessments
- Targeted go-to-market strategies - identifying opportunities, barriers, and enablers
- Product launches and portfolio and lifecycle management
- Strategy implementation
Our work with BD&L opportunities cuts across Commercial, R&D, Clinical, Market Access, and Medical Affairs. It includes:
- Initial landscape assessments
- Outside in evaluation
- Commercial and business due diligence
- Partnership and engagement structures
- Development of 100-day plans and integration of critical activities
It's all about partnership
We have served
0+
clients
We have transformed
0+
functions and organizations
We have partnered on
0+
projects
"You guys have helped us create a high-performing team. It is something I have hardly seen...a team performance of that quality. We were constantly challenged to raise the bar. Not only that, you came up with very good ideas of how to accomplish that. In this project I have never experienced something like that...the team members were sad when it was over."
Five reasons you will love working with us
We often hear leaders say they don't like working with consultants. We don't take offence. In fact, it's why we started Genioo – to defy the convention of traditional consulting. Here's how we overcome the pain points:
You and your team stay in control of your transformation.
Our support model is flexible and cost-effective.
We partner with your team to understand your business.
We never work in silos and aim to reduce consulting dependency.
We address risks and roadblocks from the outset.
The Genioo Way in Action
Case study
Codifying product launch preparations to successfully bring 12 $100m-$1bn NMEs to market over 5 years
Case study
For a leading pharma, bringing 12 new molecular entities to market in five years would demand a significant investment of time and resource across teams with no clear path to global product launch success.
The company partnered with Genioo and working as One Team across R&D, Commercial, Access, and Medical we co-created and codified global launch preparations to smooth and accelerate product launch and ready the team to optimize the $100m- 1bn values in its NMEs.
Case study
An ambitious TechOps transformation at a leading global generics pharma yields cost savings of $200m+
Case study
Following a top-tier firm benchmarking, a global generics firm needed help to turn an on-paper TechOps transformation strategy into practical reality.
The program spanned 150+ initiatives across multiple chemical, manufacturing, and control (CMC) functions. The high stakes of a potential $200m cost savings and a TechOps organization ready for a more cost-efficient, digitally enabled, and agile way of working, demanded strong program ownership and drive.
Case study
Reimagining Global Procurement at a leading biotech to drive innovation and value creation through agile ways of working
Case study
For a Global Portfolio & Resource Management (PRM) at a leading biotech, a customer-centric operating model would help it partner across the business to evaluate, support and resource projects.
We helped the team align on customer personas, service design considerations, and organizational structure and to develop tools and templates to serve customers better set up for future digitilization.
Case study
Applying design to cost to radically cut production cost and time for a groundbreaking cell therapy
Case study
Following Phase II clinical trials, a leading biotech needed to significantly reduce costs and turnaround time (time to patient) to bring its innovative cell therapy to market in under 18 months.
The company turned to Genioo to remove the distraction of scaling production for Phase III trials to ramp up the program and engage 50+ stakeholders across CMC to design an innovative production strategy and create a clear pathway to cut turnaround times in half and reduce costs by a factor of 25.
Case study
Unlocking hundreds of millions USD trapped in redundant POs
Case study
Following a post-pandemic rapid decline in sales, a leading global pharma needed to prevent millions in losses through supplier PO cancellations whilde protecting relationships.
Genioo partnered across supply chain, procurement, and finance to get transparency and alignment on the scale of the problem and solutions. Comprehensive analysis identified a 60% potential loss reduction in POs and inventory and guided supplier renegotiations, and clinical collaboration enabled 50% of total reductions to come from shelf-life extensions.
Case study
An engagement blueprint helps relaunch a drug and retain 40% market share
Case study
A global pharma needed to launch a new formulation of a leading drug to health professionals and patients. Switching patients over had been impacted by a lack of communication on the new formulation.
We partnered with R+D and Commercial to co-create a launch and engagement blueprint to target key audiences with traditional and digital/social channels. In 11 months, we relaunched in 20+ EU countries, retained 40%+ market share, and gained global market access.
Case study
A Procurement partnership with IT identifies a $4m+ spend reduction and deepens supplier relationships
Case study
Significant growth in employee nos had seen external IT spend for a global pharma rocket with little transparency and oversight for procurement.
Genioo partnered with tthe CPO and IT to conduct a detailed spend analysis. As One Team, we reviewed over 100 supplier contracts and identified product harmonization and volume-based opportunities to renegotiate better terms on strategic supplier contracts and deepen supplier relationships to deliver £2m+ year one spend savings and £4m in total.
Case study
Global Supply Chain transformation readiness to deliver >$1bn savings
Case study
For a global biotech, its industry leading OTIF meant high inventory and costly write-offs. Digital transformation and ERP/Nexus integration would create a superior global supply chain to drive patient value. But a self-assessment indicated significant gaps in transformation readiness.
Genioo partnered across global/local Supply Chain, IT, Manufacturing, and Commercial to address the many interdependencies and set the team up for a successful transformation to reduce inventory and cost to serve to save $1.9bn.
Case study
Deepening supply chain connections across 9 multinational sites secures supply to protect patients
Case study
For a leading global biotech, supply chain issues put patient care at risk. Determined to secure supply through better supply risk management and planning processes, the team turned to Genioo to connect across its nine multinational sites, all operating independently, at different levels of maturity.
Together, we collated c.2000 inputs on existing practices, pain points, and performance to prioritize 11 initiatives to harmonize sourcing and planning and deepen collaboration.
